Catalog No.
PHC45341
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human C4 (Thr1021-Thr1330).
Conjugation
FITC
Target
CO4, CPAMD2, Acidic complement C4, C4A, Complement C4-A, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2
Purification
Purified by antigen affinity column.
Accession
P0C0L5
Applications
ELISA, IF, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Combined proteomics and metabolomics analysis reveal the effect of a training course on the immune function of Chinese elite short-track speed skaters., PMID:39352112
HPV and systemic lupus erythematosus: a mosaic of potential crossreactions., PMID:28111707
Serum protein profile of Crohn's disease treated with infliximab., PMID:23562004
Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive., PMID:9364680
Comparison of the C-mediating killing activity and C-activating properties of mouse monoclonal and polyclonal antibodies against Trypanosoma cruzi., PMID:18475476
Immunomodulatory properties of cimetidine in ARC patients., PMID:2968205
A monoclonal antibody which can distinguish between the two isotypes of human C4., PMID:3614207
The purification and properties of some less common allotypes of the fourth component of human complement., PMID:2430883
The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6., PMID:3852741
Guillain-Barré syndrome following danazol and corticosteroid therapy for hereditary angioedema., PMID:4014294
Structural polymorphism of murine C4 and its linkage to H-2., PMID:7373044
Serum complement pattern in essential mixed cryoglobulinaemia., PMID:668194
Interactions of the third component of complement (C3) with cross-linked dextran. II. Demonstration of an alternate pathway activation as binding mechanism of C3 to cross-linked dextran., PMID:127458
For research use only. Not for human or drug use.
